Prognostic value of fully-automatic Metabolic Tumor Volume calculation for patients with metastatic lung cancer treated with immunotherapy

被引：0
|
作者：
Humbert, O. [1 ]
Tricarico, P. [1 ]
Cheze-Le-Rest, C. [2 ]
Pace-Loscos, T. [1 ]
Ferrari, V. [1 ]
Lamazou, G. [3 ]
El Jurdi, R. [3 ]
Schalck, E. [3 ]
机构：
[1] Antoine Lacassagne Canc Ctr, Nice, France
[2] CHU, Poitiers, France
[3] EuraNova, Marseille, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-163
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [1] Prognostic value of tumor volume for patients with advanced lung cancer treated with chemotherapy
    Kuo, Chung-Feng Jeffrey
    Ke, Bo-Han
    Wu, Nain-Ying
    Kuo, Joseph
    Hsu, Hsian-He
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2017, 144 : 165 - 177
  • [2] Baseline metabolic tumor volume has a strong predictive and prognostic value in non-small cell lung cancer patients treated with immunotherapy
    Chardin, David
    Paquet, Marie
    Schiappa, Renaud
    Darcourt, Jacques
    Bailleux, Caroline
    Poudenx, Michel
    Schiazza, Aurelie
    Ilie, Marius
    Martin, Nicolas
    Otto, Josiane
    Humbert, Olivier
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [3] Prognostic value of preoperative metabolic tumor volume in patients with rectal cancer
    Hong, Chae Moon
    Ahn, Byeong-Cheol
    Kim, Do-Hoon
    Lee, Sang-Woo
    Lee, Jaetae
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [4] The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
    Pan, Yuting
    Ma, Yue
    Dai, Guanghai
    NUTRIENTS, 2023, 15 (19)
  • [5] Prognostic value of metabolic tumor burden in lung cancer
    Piotr Obara
    Yonglin Pu
    Chinese Journal of Cancer Research, 2013, 25 (06) : 615 - 622
  • [6] Prognostic value of metabolic tumor burden in lung cancer
    Obara, Piotr
    Pu, Yonglin
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (06) : 615 - 622
  • [7] Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy
    Tricarico, Pierre
    Chardin, David
    Martin, Nicolas
    Contu, Sara
    Hugonnet, Florent
    Otto, Josiane
    Humbert, Olivier
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [8] Prognostic biomarkers in lung cancer patients treated with immunotherapy
    Ferreira, S.
    Esteves, S.
    Almodovar, M. T. A. S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] Prognostic Value of Change in Platelet Volume for Patients with Metastatic Non-small Cell Lung Cancer Treated with Pembrolizumab
    Li, M.
    Zhao, S.
    Chian, K.
    Chakravarthy, K.
    Kwon, H.
    Gauntner, T.
    Jones, N.
    Secor, A.
    Das, P.
    Surya, N.
    Zehr, B.
    Spakowicz, D.
    Wei, L.
    He, K.
    Alahmadi, A.
    Memmott, R.
    Kaufman, J.
    Shields, P. G.
    Li, Z.
    Carbone, D. P.
    Presley, C. J.
    Otterson, G. A.
    Owen, D. H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S240 - S241
  • [10] Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non-Small-Cell Lung Cancer
    Lee, Percy
    Bazan, Jose G.
    Lavori, Philip W.
    Weerasuriya, Dilani K.
    Quon, Andrew
    Quynh-Thu Le
    Wakelee, Heather A.
    Graves, Edward E.
    Loo, Billy W.
    CLINICAL LUNG CANCER, 2012, 13 (01) : 52 - 58
12345